| Heading: |
Alzheimer's Disease: Diagnosis |
| Question ID: |
1805143 |
| UIN: |
54180 |
| House: |
Commons |
| Date tabled: |
2025-05-21 |
| Asking Member ID: |
5296 |
| Asking Member display name: |
Freddie van Mierlo
|
| Asking Member handle: |
|
| Asking Member Twitter reference: |
Freddie van Mierlo
|
| Member interest: |
false |
| Question text: |
To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential merits of using (a) PET scans, (b) cerebrospinal fluid testing and (c) other bio-marker led tests to confirm Alzheimer's disease. |
| Is named day: |
true |
| Date of holding answer: |
|
| Date answered: |
2025-06-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
4359 |
| Answering Member display name: |
Stephen Kinnock
|
| Answering Member handle: |
skinnock
|
| Answering Member Twitter reference: |
@skinnock
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The Department delivers dementia research through the National Institute for Health and Care Research (NIHR). The NIHR funds a range of research into dementia, for example investing almost £11 million to develop new digital approaches for the early detect... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |